Cargando…
Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells
Classical anti-mitotic drugs have failed to translate their preclinical efficacy into clinical response in human trials. Their clinical failure has challenged the notion that tumor cells divide frequently at rates comparable to those of cancer cells in vitro and in xenograft models. Given the prepon...
Autores principales: | Pannu, V, Rida, P C G, Celik, B, Turaga, R C, Ogden, A, Cantuaria, G, Gopalakrishnan, J, Aneja, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260758/ https://www.ncbi.nlm.nih.gov/pubmed/25412316 http://dx.doi.org/10.1038/cddis.2014.505 |
Ejemplares similares
-
Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death
por: Ogden, A, et al.
Publicado: (2014) -
HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients
por: Pannu, Vaishali, et al.
Publicado: (2015) -
Nek5 promotes centrosome integrity in interphase and loss of centrosome cohesion in mitosis
por: Prosser, Suzanna L., et al.
Publicado: (2015) -
Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors
por: Ogden, Angela, et al.
Publicado: (2017) -
Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: a novel chemotherapeutic approach
por: Pannu, V, et al.
Publicado: (2012)